Verrica Pharmaceuticals Inc.(VRCA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VRCA Verrica Pharmaceuticals Inc.

交易中 03-04 15:30:03 EST

5.39

+0.27

+5.27%

最高5.50	最低5.13	成交量8.68万
今开5.15	昨收5.12	日振幅7.23%
总市值8,619万	流通市值1,043万	总股本1,599万
成交额46.56万	换手率4.49%	流通股本193.56万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VRCA","market":"US","secType":"STK","nameCN":"Verrica Pharmaceuticals Inc.","latestPrice":5.39,"timestamp":1772656099624,"preClose":5.12,"halted":0,"volume":86830,"delay":0,"changeRate":0.05273437499999992,"floatShares":1935557,"shares":15989861,"eps":-2.955175,"marketStatus":"交易中","change":0.27,"latestTime":"03-04 15:30:03 EST","open":5.15,"high":5.5,"low":5.13,"amount":465550.24607,"amplitude":0.072266,"askPrice":5.41,"askSize":10,"bidPrice":5.39,"bidSize":121,"shortable":3,"etf":0,"ttmEps":-2.955175,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772658000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1529035200000,"exchange":"NASDAQ","adjPreClose":5.12,"preHourTrading":{"tag":"盘前","latestPrice":5.03,"preClose":5.12,"latestTime":"09:27 EST","volume":40,"amount":201.20000000000002,"timestamp":1772634459033,"change":-0.09,"changeRate":-0.017578,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":5.12,"preClose":5.12,"latestTime":"19:20 EST","volume":35,"amount":178,"timestamp":1772583636338,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.917932,"impliedVol":0.3196,"impliedVolPercentile":0.6768},"requestUrl":"/m/hq/s/VRCA","defaultTab":"news","newsList":[{"id":"1135604881","title":"Verrica制药宣布合作伙伴鸟居药品在日本推出Ycanth®用于传染性软疣治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1135604881","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135604881?lang=zh_cn&edition=full","pubTime":"2026-02-09 21:05","pubTimestamp":1770642317,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc.（简称：Verrica制药）宣布，其合作伙伴鸟居药品株式会社已在日本市场正式推出Ycanth®（cantharidin，0.7% topical solution），该产品获批用于治疗传染性软疣。这一重要进展标志着Verrica制药的核心产品成功进入全球主要医药市场之一，将为日本患者提供一种全新的非侵入性治疗选择。Ycanth®是首个且目前唯一经美国FDA批准、采用专有技术平台开发的传染性软疣局部治疗药物，其活性成分斑蝥素通过靶向病变部位实现有效治疗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2608095458","title":"Verrica制药盘中异动 股价大跌5.50%报7.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608095458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608095458?lang=zh_cn&edition=full","pubTime":"2026-02-04 01:17","pubTimestamp":1770139039,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日01时17分，Verrica制药股票出现波动，股价急速跳水5.50%。截至发稿，该股报7.04美元/股，成交量3.7485万股，换手率0.23%，振幅4.83%。机构评级方面，在所有5家参与评级的机构中，80%的券商给予买入建议，20%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体跌幅为0.10%。Verrica制药公司简介：Verrica Pharmaceuticals Inc是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的益处的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020401171997a4b71f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020401171997a4b71f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"1185762151","title":"Verrica制药启动Ycanth®（VP-102）治疗寻常疣三期临床项目 首位患者完成给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1185762151","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185762151?lang=zh_cn&edition=full","pubTime":"2026-01-07 21:04","pubTimestamp":1767791059,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. (VRCA) 宣布，其针对寻常疣治疗的三期临床试验项目已完成首位患者给药。该研究旨在评估候选药物Ycanth®（VP-102）的疗效与安全性。\n作为一款创新疗法，Ycanth®若通过临床验证，有望为常见皮肤疾病患者提供新的治疗选择。此次三期项目的推进标志着该药物研发进入关键阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2601281334","title":"Verrica制药盘中异动 股价大涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601281334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601281334?lang=zh_cn&edition=full","pubTime":"2026-01-05 23:17","pubTimestamp":1767626258,"startTime":"0","endTime":"0","summary":"北京时间2026年01月05日23时17分，Verrica制药股票出现异动，股价急速拉升5.40%。截至发稿，该股报8.75美元/股，成交量9313股，换手率0.06%，振幅6.85%。Verrica制药股票所在的生物技术行业中，整体跌幅为1.80%。Verrica制药公司简介：Verrica Pharmaceuticals Inc是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的益处的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105231738a49f885e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105231738a49f885e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2593942021","title":"Verrica制药盘中异动 早盘股价大涨6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593942021","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593942021?lang=zh_cn&edition=full","pubTime":"2025-12-23 22:54","pubTimestamp":1766501655,"startTime":"0","endTime":"0","summary":"北京时间2025年12月23日22时54分，Verrica制药股票出现波动，股价急速拉升6.19%。截至发稿，该股报8.40美元/股，成交量3.877万股，换手率0.24%，振幅5.56%。Verrica制药股票所在的生物技术行业中，整体涨幅为0.05%。Verrica制药公司简介：Verrica Pharmaceuticals Inc是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的益处的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223225415a6c67014&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223225415a6c67014&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2588502160","title":"Verrica制药盘中异动 早盘股价大跌5.70%报7.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588502160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588502160?lang=zh_cn&edition=full","pubTime":"2025-12-03 00:21","pubTimestamp":1764692513,"startTime":"0","endTime":"0","summary":"北京时间2025年12月03日00时21分，Verrica制药股票出现异动，股价大幅下跌5.70%。截至发稿，该股报7.12美元/股，成交量8.6352万股，换手率0.91%，振幅4.24%。机构评级方面，在所有4家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体跌幅为0.15%。Verrica制药公司简介：Verrica Pharmaceuticals Inc是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的益处的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203002153a4c87566&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203002153a4c87566&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"1153578772","title":"Verrica Pharmaceuticals Inc. - 与机构投资者签订证券购买协议 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1153578772","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153578772?lang=zh_cn&edition=full","pubTime":"2025-11-25 00:21","pubTimestamp":1764001286,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. - 与机构投资者签订证券购买协议 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"1109667485","title":"Verrica Pharmaceuticals 宣布5000万美元的私募融资，以偿还债务并延长现金储备","url":"https://stock-news.laohu8.com/highlight/detail?id=1109667485","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109667485?lang=zh_cn&edition=full","pubTime":"2025-11-24 21:01","pubTimestamp":1763989275,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals 宣布5000万美元的私募融资，以偿还债务并延长现金储备。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"1142780870","title":"Verrica Pharmaceuticals在第40届癌症免疫治疗学会年会上发布Vp-315的二期临床试验新数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1142780870","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142780870?lang=zh_cn&edition=full","pubTime":"2025-11-10 21:06","pubTimestamp":1762779988,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals在第40届癌症免疫治疗学会年会上发布Vp-315的二期临床试验新数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2581274687","title":"Verrica制药盘中异动 早盘大幅下挫5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581274687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581274687?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:40","pubTimestamp":1762267201,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日22时40分，Verrica制药股票出现波动，股价大幅跳水5.34%。截至发稿，该股报3.37美元/股，成交量1.2852万股，换手率0.14%，振幅4.76%。Verrica制药股票所在的生物技术行业中，整体跌幅为0.69%。Verrica制药公司简介：Verrica Pharmaceuticals Inc是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的益处的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104224002a6e0b9e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104224002a6e0b9e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TERN","VRCA","BK4007"],"gpt_icon":0},{"id":"1190273267","title":"Verrica Pharmaceuticals Inc.宣布合作伙伴Torii Pharmaceutical的Ycanth®(to-208)在日本获批用于治疗传染性软疣","url":"https://stock-news.laohu8.com/highlight/detail?id=1190273267","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190273267?lang=zh_cn&edition=full","pubTime":"2025-09-19 20:00","pubTimestamp":1758283214,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc.宣布其开发合作伙伴Torii Pharmaceutical的Ycanth®(to-208)药物在日本获得批准，用于治疗传染性软疣。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2568044773","title":"Verrica制药盘中异动 早盘股价大涨7.94%报4.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568044773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568044773?lang=zh_cn&edition=full","pubTime":"2025-09-17 21:33","pubTimestamp":1758115990,"startTime":"0","endTime":"0","summary":"北京时间2025年09月17日21时33分，Verrica制药股票出现异动，股价急速拉升7.94%。截至发稿，该股报4.76美元/股，成交量847股，换手率0.01%，振幅0.00%。Verrica制药股票所在的生物技术行业中，整体涨幅为0.30%。Verrica制药公司简介：Verrica Pharmaceuticals Inc是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的益处的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250917213310a72672f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250917213310a72672f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2518227291","title":"Verrica制药盘中异动 临近午盘快速拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518227291?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:46","pubTimestamp":1741621565,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时46分，Verrica制药股票出现异动，股价急速上涨5.30%。截至发稿，该股报0.640美元/股，成交量13.9209万股，换手率0.15%，振幅7.71%。Verrica制药股票所在的生物技术行业中，整体涨幅为0.14%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023460696405344&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023460696405344&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2516677013","title":"Verrica制药盘中异动 早盘股价大跌7.44%报0.593美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677013?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:46","pubTimestamp":1741099583,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时46分，Verrica制药股票出现波动，股价快速下跌7.44%。截至发稿，该股报0.593美元/股，成交量9.0819万股，换手率0.10%，振幅11.19%。机构评级方面，在所有5家参与评级的机构中，40%的券商给予买入建议，60%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体涨幅为0.36%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224623989bb086&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224623989bb086&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2514378122","title":"Verrica制药盘中异动 早盘股价大涨5.07%报0.620美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514378122?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753116,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Verrica制药股票出现异动，股价大幅上涨5.07%。截至发稿，该股报0.620美元/股，成交量7287股，换手率0.01%，振幅0.00%。机构评级方面，在所有4家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体涨幅为0.02%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223156989679bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223156989679bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRPX","VRCA"],"gpt_icon":0},{"id":"2514380226","title":"Verrica制药盘中异动 股价大跌6.70%报0.662美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514380226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514380226?lang=zh_cn&edition=full","pubTime":"2025-02-28 01:01","pubTimestamp":1740675685,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日01时01分，Verrica制药股票出现异动，股价急速下跌6.70%。截至发稿，该股报0.662美元/股，成交量12.3952万股，换手率0.14%，振幅6.39%。机构评级方面，在所有5家参与评级的机构中，40%的券商给予买入建议，60%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体涨幅为0.40%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228010126abdf91c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228010126abdf91c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2514685274","title":"Verrica制药盘中异动 快速拉升6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514685274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514685274?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:06","pubTimestamp":1740585987,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时06分，Verrica制药股票出现波动，股价急速拉升6.04%。截至发稿，该股报0.720美元/股，成交量4.6793万股，换手率0.05%，振幅4.71%。Verrica制药股票所在的生物技术行业中，整体涨幅为0.19%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270006279631619d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270006279631619d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2514726687","title":"Verrica制药盘中异动 大幅下跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514726687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514726687?lang=zh_cn&edition=full","pubTime":"2025-02-25 02:16","pubTimestamp":1740421006,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日02时16分，Verrica制药股票出现异动，股价急速下挫5.27%。截至发稿，该股报0.697美元/股，成交量11.4309万股，换手率0.13%，振幅8.68%。Verrica制药股票所在的生物技术行业中，整体跌幅为0.37%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225021646962ec798&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225021646962ec798&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2512481564","title":"Verrica制药盘中异动 急速下跌6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512481564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512481564?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:52","pubTimestamp":1739980334,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时52分，Verrica制药股票出现异动，股价大幅下挫6.04%。截至发稿，该股报0.689美元/股，成交量10.3381万股，换手率0.11%，振幅8.64%。机构评级方面，在所有5家参与评级的机构中，40%的券商给予买入建议，60%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体涨幅为0.55%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219235214988b3e3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219235214988b3e3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2512657141","title":"Verrica制药盘中异动 早盘急速拉升5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512657141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512657141?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:42","pubTimestamp":1739889748,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时42分，Verrica制药股票出现异动，股价急速上涨5.85%。截至发稿，该股报0.780美元/股，成交量3.1254万股，换手率0.03%，振幅2.50%。机构评级方面，在所有5家参与评级的机构中，40%的券商给予买入建议，60%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体涨幅为0.55%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182242289889ff3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182242289889ff3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","PULM","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.verrica.com","stockEarnings":[{"period":"1week","weight":-0.0841},{"period":"1month","weight":-0.2717},{"period":"3month","weight":-0.3155},{"period":"6month","weight":-0.0078},{"period":"1year","weight":-0.2001},{"period":"ytd","weight":-0.3839}],"compareEarnings":[{"period":"1week","weight":-0.0102},{"period":"1month","weight":-0.0168},{"period":"3month","weight":-0.0052},{"period":"6month","weight":0.0481},{"period":"1year","weight":0.1654},{"period":"ytd","weight":-0.0023}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Verrica Pharmaceuticals Inc.于2013年7月3日根据特拉华州法律注册成立。该公司是一家临床阶段医疗皮肤科公司，致力于识别，开发和商业化用于治疗皮肤疾病的创新药物产品，并满足重大需求。该公司的首席产品候选人VP-102是一种专利药物设备组合，其新颖的斑rid素局部溶液是一种广泛认可的天然来源的治疗局部皮肤病的药物，通过其一次性使用精确施药器进行施用。该公司最初正在开发用于治疗传染性软疣或软体动物的VP-102，这是一种高度传染性的，主要是儿科病毒性皮肤病和常见的疣。目前美国食品和药物管理局或FDA没有批准任何产品，也没有针对这些疾病的既定标准护理，导致皮肤科中两个最大的未满足需求的重要未经治疗的人群。除了他们正在寻求的专利保护外，VP-102还有可能成为FDA批准的第一个用于软体动物及其活性药物成分或API的新产品，即新化学实体或NCE，多年与该指定相关的非专利监管排他性。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.064974},{"month":2,"riseRate":0.5,"avgChangeRate":0.04305},{"month":3,"riseRate":0.25,"avgChangeRate":-0.059014},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.016247},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.140402},{"month":6,"riseRate":0.571429,"avgChangeRate":0.076173},{"month":7,"riseRate":0.5,"avgChangeRate":0.012098},{"month":8,"riseRate":0.5,"avgChangeRate":-0.04466},{"month":9,"riseRate":0.25,"avgChangeRate":-0.080364},{"month":10,"riseRate":0.125,"avgChangeRate":-0.088008},{"month":11,"riseRate":0.5,"avgChangeRate":0.227615},{"month":12,"riseRate":0.375,"avgChangeRate":0.021484}],"exchange":"NASDAQ","name":"Verrica Pharmaceuticals Inc.","nameEN":"Verrica Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Verrica Pharmaceuticals Inc.(VRCA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Verrica Pharmaceuticals Inc.(VRCA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Verrica Pharmaceuticals Inc.,VRCA,Verrica Pharmaceuticals Inc.股票,Verrica Pharmaceuticals Inc.股票老虎,Verrica Pharmaceuticals Inc.股票老虎国际,Verrica Pharmaceuticals Inc.行情,Verrica Pharmaceuticals Inc.股票行情,Verrica Pharmaceuticals Inc.股价,Verrica Pharmaceuticals Inc.股市,Verrica Pharmaceuticals Inc.股票价格,Verrica Pharmaceuticals Inc.股票交易,Verrica Pharmaceuticals Inc.股票购买,Verrica Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Verrica Pharmaceuticals Inc.(VRCA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Verrica Pharmaceuticals Inc.(VRCA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}